» Authors » Cristina Cappelletti

Cristina Cappelletti

Explore the profile of Cristina Cappelletti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 271
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Morpurgo M, Marrone F, Ciutti F, Cappelletti C, Vorhauser S, Alber R, et al.
Biology (Basel) . 2024 Apr; 13(4). PMID: 38666814
Olindiid freshwater jellyfishes of the genus Lankester, 1880 are native to eastern Asia; however, some species within the genus have been introduced worldwide and are nowadays present in all continents...
2.
Brugnoni R, Marelli D, Iacomino N, Canioni E, Cappelletti C, Maggi L, et al.
Genes (Basel) . 2023 Sep; 14(9). PMID: 37761893
Schwartz-Jampel syndrome type 1 (SJS1) is a rare autosomal recessive musculoskeletal disorder caused by various mutations in the gene encoding the protein perlecan, a major component of basement membranes. We...
3.
Cappelletti C, Brugnoni R, Bonanno S, Andreetta F, Salerno F, Canioni E, et al.
Eur J Immunol . 2023 Aug; 53(11):e2250326. PMID: 37562045
We aimed to verify whether the immune system may represent a source of potential biomarkers for the stratification of immune-mediated necrotizing myopathies (IMNMs) subtypes. A group of 22 patients diagnosed...
4.
Tiraboschi P, Xhani R, Zerbi S, Corso A, Martinelli I, Fusi L, et al.
J Nucl Med . 2021 May; 62(8):1171-1176. PMID: 34016729
A 40-y-old woman with severe acute respiratory syndrome coronavirus 2 infection developed neurologic manifestations (confusion, agitation, seizures, dyskinesias, and parkinsonism) a few weeks after the onset of severe acute respiratory...
5.
Cappelletti C, Tramacere I, Cavalcante P, Schena E, Politano L, Carboni N, et al.
Cells . 2020 Jun; 9(6). PMID: 32585971
Laminopathies are a wide and heterogeneous group of rare human diseases caused by mutations of the LMNA gene or related nuclear envelope genes. The variety of clinical phenotypes and the...
6.
Favoni V, Crisci M, Borghi A, Zaniboni A, Nicodemo M, Cappelletti C, et al.
Neurol Sci . 2020 Apr; 41(10):2981-2983. PMID: 32333182
No abstract available.
7.
Buscarinu M, Fornasiero A, Pellicciari G, Renie R, Landi A, Bozzao A, et al.
Brain Sci . 2019 Nov; 9(11). PMID: 31671619
A 45-year-old Italian woman, affected by relapsing-remitting multiple sclerosis (RR-MS) starting from 2011, started treatment with alemtuzumab in July 2016. Nine months after the second infusion, she had an immune...
8.
Marcuzzo S, Terragni B, Bonanno S, Isaia D, Cavalcante P, Cappelletti C, et al.
Neuroscience . 2019 Aug; 416:88-99. PMID: 31400485
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting the corticospinal tract and leading to motor neuron death. According to a recent study, magnetic resonance imaging-visible changes suggestive of neurodegeneration...
9.
Dilena R, Mauri E, Aronica E, Bernasconi P, Bana C, Cappelletti C, et al.
Epilepsia Open . 2019 Jun; 4(2):344-350. PMID: 31168503
Febrile infection-related epilepsy syndrome (FIRES) is a severe epileptic encephalopathy with presumed inflammatory origin and lacking effective treatments. Anakinra is the human recombinant interleukin 1 receptor antagonist clinically used in...
10.
Cappelletti C, Galbardi B, Bruttini M, Salerno F, Canioni E, Pasanisi M, et al.
FASEB J . 2019 Mar; 33(6):7155-7167. PMID: 30860873
Oculopharyngeal muscular dystrophy (OPMD) is a late-onset muscle disease caused by an abnormal (GCN) triplet expansion within the polyadenylate-binding protein nuclear 1 gene and consequent mRNA processing impairment and myogenic...